CTD O 6.25/20

AboutCTD O 6.25/20 is a fixed-dose combination medication containing Chlorthalidone (6.25mg) and Olmesartan (20mg). Chlorthalidone is a long-acting thiazide-like diuretic that promotes the excretion of sodium and water, thereby reducing extracellular fluid volume and lowering blood pressure. Olmesartan is an Angiotensin Receptor Blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor in various tissues, leading to vasodilation, reduced aldosterone secretion, and decreased sympathetic activity. This dual mechanism of action provides a potent antihypertensive effect, making it suitable for patients whose blood pressure is not adequately controlled by monotherapy. The combination is particularly effective in achieving target blood pressure goals and reducing the risk of cardiovascular events associated with hypertension. Its once-daily dosing regimen enhances patient compliance and simplifies treatment.UsesTreatment of essential hypertensionReduction of cardiovascular morbidityManagement of fluid retention in certain conditionsAdjunctive therapy in heart failure managementDirections For UseAdminister orally once daily, preferably at the same time each day, with or without food.BenefitsProvides significant and sustained blood pressure reductionOffers comprehensive cardiovascular protectionConvenient once-daily dosing improves adherenceSynergistic action of two antihypertensive agentsHelps prevent hypertension-related organ damageWell-tolerated in many patient populationsSide EffectsDizziness or lightheadednessFatigue or weaknessHeadacheLow blood pressure (hypotension)Electrolyte disturbances (e.g., hypokalemia, hyponatremia)Kidney impairment or increased creatinineMuscle cramps or painNausea or diarrheaIncreased uric acid levelsHyperglycemiaUpper respiratory tract infectionBack painSafety MeasuresAlcohol - Alcohol can exacerbate hypotensive effects and increase the risk of dizziness. Use with caution.Pregnancy - Contraindicated during the second and third trimesters due to severe risk of fetal injury and death.Breastfeeding - Not advised during breastfeeding as components may be excreted in breast milk. Consult a healthcare professional.Liver - Use with caution in patients with hepatic impairment; dose adjustment may be necessary.Kidney - Avoid in severe renal dysfunction; close monitoring of kidney function is essential.Lung - Generally safe, but monitor for electrolyte imbalances that could indirectly affect respiratory status.DisclaimerMedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.Our goal is to complement, not replace, the essential doctor-patient relationship.